• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G154
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/06/2020
Event Type  malfunction  
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) had entered safety mode and had required three resets to obtain this status.This device was not implanted; no patient involvement reported.
 
Manufacturer Narrative
Correction: b5 updated for clarity.Upon receipt at our post market quality assurance laboratory, the device was confirmed to be operating in safety mode as was reported from the field.Memory review confirmed that the device underwent a reset due to memory corruption.A memory error was recorded on september 15, 2020 followed by three device faults.It is normal device function for this product to revert to safety mode after detecting three faults in a short period of time.The device reverted to a safety mode with limited programmability, in which single chamber pacing and defibrillation therapy were available.Detailed analysis determined the root cause of the memory corruption appeared to be due to an issue with a digital integrated circuit component.The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that upon device interrogation prior to implant, this cardiac resynchronization therapy defibrillator (crt-d) had entered safety mode.This device was not implanted and was returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key11182967
MDR Text Key227553354
Report Number2124215-2020-28125
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534652
UDI-Public00802526534652
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/28/2022
Device Model NumberG154
Device Catalogue NumberG154
Device Lot Number105148
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/28/2020
Date Manufacturer Received12/13/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/18/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-